tailieuchung - Phase I clinical study of oral olaparib in pediatric patients with refractory solid tumors: Study protocol

Đang chuẩn bị liên kết để tải về tài liệu:
Phase I clinical study of oral olaparib in pediatric patients with refractory solid tumors: Study protocol

Dạ Hương 58 7 pdf

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ Tải xuống

There is no established standard chemotherapy for recurrent pediatric solid tumors such as neuroblastoma and sarcoma. Since some of these tumor cells show dysfunctions in homologous recombination repair, the goal is to conduct a phase I study of olaparib, a poly(ADP-ribose) polymerase inhibitor. | Phase I clinical study of oral olaparib in pediatric patients with refractory solid tumors: Study protocol

Đang chuẩn bị liên kết để tải về tài liệu:
Phase I clinical study of oral olaparib in pediatric patients with refractory solid tumors: Study protocol

Optimal biological dose: A systematic review in cancer phase I clinical trials

A first in human, safety, pharmacokinetics, and clinical activity phase I study of once weekly administration of the Hsp90 inhibitor ganetespib (STA-9090) in patients with solid malignancies

A phase I study of the safety and activity of K-001 in patients with advanced pancreatic ductal adenocarcinoma

Phase I clinical study of oral olaparib in pediatric patients with refractory solid tumors: Study protocol

A phase I study evaluating the pharmacokinetics, safety and tolerability of an antibody-based tissue factor antagonist in subjects with acute lung injury or acute respiratory distress syndrome

Treatment of advanced gastrointestinal tumors with genetically modified autologous mesenchymal stromal cells (TREAT-ME1): Study protocol of a phase I/II clinical trial

Single fraction ablative preoperative radiation treatment for early-stage breast cancer: The CRYSTAL study – a phase I/II clinical trial protocol

Phase I clinical study of brentuximab vedotin (SGN-35) involving children with recurrent or refractory CD30-positive Hodgkin’s lymphoma or systemic anaplastic large cell lymphoma: rationale, design and methods of BV-HLALCL study: Study protocol

Báo cáo y học: " Assessment of pulmonary antibodies with induced sputum and bronchoalveolar lavage induced by nasal vaccination against Pseudomonas aeruginosa: a clinical phase I/II study"

Chemoradiation in elderly esophageal cancer patients: Rationale and design of a phase I/II multicenter study (OSAGE)

Đang chuẩn bị liên kết để tải về tài liệu: Phase I clinical study of oral olaparib in pediatric patients with refractory solid tumors: Study protocol